Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain
Active, not recruitingNCT04598035
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of the ESCAPE Study is to determine the extent to which epidural spinal cord stimulation (SCS) reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension. We also aim to determine the extent to which higher baseline BP (i.e., hypertension) predicts reductions in pain following SCS implant. This is an observational study of patients undergoing an implantation of a SCS device.
Study details
- Official title
- Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain
- Conditions
- Chronic Pain
- Hypertension
- Implanted Stimulation Electrodes
- Interventions
- Diagnostic test: Diagnostic Tests
- Sponsor
- University of Kansas Medical Center
- Start date
- 2020-11-01
- Primary completion
- 2025-11-01
- Sex
- All
- Age range
- from 30 Years to 89 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
* Planning to have an epidural spinal cord stimulation device implanted at KUMC * Male or Female, age 30-89 * Low back pain for more than 3 months * Willing to visit research lab * Willing to undergo a blood draw and blood pressure measures * Able to provide written informed consent
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04598035